ReCor Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, ReCor Medical sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
ReCor Medical: 5 sponsored US clinical trials, 2 recruiting.
ReCor Medical sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Vascular Diseases, with 5 trials.
Upper-quartile sponsor footprint
ReCor Medical sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The RADIANCE CED Study
NCT07231757
Global Paradise System US Post Approval Study
NCT06297291
RADIANCE Continued Access Protocol
NCT05017935
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260
A Study of the ReCor Medical Paradise System in Clinical Hypertension
NCT02649426
Therapeutic Areas
What is open in the ReCor Medical pipeline
2 recruiting of 5 indexed (40% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Vascular Diseases (5 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ReCor Medical: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
ReCor Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this ReCor Medical page
5 registered trials is a research-attention snapshot, not an endorsement of ReCor Medical or any single study.
- 2 of ReCor Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vascular Diseases is the condition ReCor Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vascular Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ReCor Medical pipeline card: 5 registered trials from official public datasets.Report a data error.